Moreover, as the PP2A phosphatase has been reported to modulate anticancer immunity (56), our finding of the CDC25B–PP2A interaction might impact tumor progression not only through regulating AMPK activity, but also through immune modulation. Here, PRKAA1 is linked to neoplasm.